about
In vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapiesNanopharmacology in translational hematology and oncologyInhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted nanoparticles for pediatric leukemia therapy.
@en
type
label
Targeted nanoparticles for pediatric leukemia therapy.
@en
prefLabel
Targeted nanoparticles for pediatric leukemia therapy.
@en
P2093
P2860
P356
P1476
Targeted nanoparticles for pediatric leukemia therapy.
@en
P2093
Andras G Lacko
Kenneth Heym
Nirupama Sabnis
Riyaz Basha
W Paul Bowman
P2860
P356
10.3389/FONC.2014.00101
P577
2014-05-13T00:00:00Z